GO
Loading...
 
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

BioMarin CEO on making a difference in patients' lives

Tue 17 Sep 13 | 06:45 PM ET
BioMarin Pharmaceutical is the developer of orphan drugs for ultra-rare genetic disorders. The stock has been red hot and is up 245 percent in the last 3 years. JJ Bienaime, CEO, provides insight into the pharmaceutical company.
 
RELATED ARTICLES AND CONTENT
More Videos
Latest Videos
Cramer wishes CNBC a Happy 25th birthday!
Thu 17 Apr 14 | 06:40 PM ET
Latest Videos
Watch out! Tax scammers, the Heartbleed vulnerability
Thu 17 Apr 14 | 06:30 PM ET
Latest Videos
Con Ed CEO: Energy-efficiency programs
Thu 17 Apr 14 | 06:25 PM ET
Latest Videos
One's man trash, another man's treasure: Cramer
Thu 17 Apr 14 | 06:00 PM ET
Go
Displaying results for: Latest Video | US